PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, OX3 7LD, UK.\', \'Janssen Research and Development, Titusville, NJ USA.\', \'Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.\', \'Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.\', \'Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, OX3, 7LD, UK.\', \'College of Medicine and Health, University of Exeter, St Luke\'s, 2LU, USA.\', \'Real World Solutions, IQVIA, Cambridge, MA, USA.\', \'VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, UT, USA.\', \'Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Tennessee Valley Healthcare System, Veterans Affairs Medical Center, Nashville, TN, USA.\', \'Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Fundació Institut Universitari per a la recerca a l\'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.\', \'Department of Biomedical Informatics, Columbia University, New York, NY, USA.\', \'New York-Presbyterian Hospital, New York, NY, USA.\', \'Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.\', \'Faculty of Medicine, Islamic University of Gaza, Palestine.\', \'Massachusetts General Hospital, Harvard Medical School, Boston, 02114, MA, USA.\', \'Faculty of Pharmacy, Cairo University, Cairo, Egypt.\', \'Digital China Health Technologies Co., LTD, Beijing 100085, China.\', \'School of Population Medicine and Public Health, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China.\', \'Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3015, Australia.\', \'Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK.\', \'Regeneron Pharmaceuticals, NY, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,, Baltimore, MD, USA.\', \'Universitat Autonoma de Barcelona, Bellaterra, Spain.\', \'Real-World Evidence, Trial Form Support, Barcelona, Spain.\', \'School of Public Health and Community Medicine, UNSW Sydney, Australia.\', \'College of Engineering, The University of Arizona Tucson, Arizona, USA.\', \'Bayer Pharmaceuticals, Sant Joan Despi, Barcelona, Spain.\', \'School of Medical Sciences, University of Manchester, UK.\', \'School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Division of Population Health Sciences, University of Dundee, Dundee, Scotland, UK.\', \'Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, USA.\', \'Health Management Institute, Southern Medical University, Guangzhou, China.\', \'Autoimmune Registry Inc., Guilford, CT 06437, USA.\', \'O\'Brien School for Public Health, Faculty of Medicine, University of Calgary, Calgary, Alberta, T2N, 1N4, Canada.\', \'Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/rheumatology/keab250
?:hasPublicationType
?:journal
  • Rheumatology (Oxford, England)
is ?:pmid of
?:pmid
?:pmid
  • 33725121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all